Incretin Atlas·MoleculesTrialsOutcomesTimelinePipelineAboutMedical Adviser's Group
Incretin Atlas › Trials › EECOH-2

EECOH-2

Ecnoglutide · t2d

Data cut 12 November 2026 · page built 16 November 2026

Design

Molecule(s)
Ecnoglutide
Population
t2d
Phase
3
Participants
623
Duration
32 weeks

Results by arm

ArmPopulationWeeksnWeight, efficacyWeight, treatment-policyHbA1c, ppAE discontinuation, %Any discontinuation, %Nausea, %Vomiting, %SAE, %SBP, mmHgStatus
0.6 mg vs dulaglutide 1.5 mg: HbA1c -1.65t2d china32623——−1.93.0—————press release
1.2 mg vs dulaglutide 1.5 mg: HbA1c -1.65t2d china32623——−1.94.0—————press release

Weight: percent change from baseline, drug vs placebo or comparator, Δ = difference in percentage points. Efficacy estimand = effect while on treatment (hypothetical strategy); treatment-policy = all randomised participants regardless of adherence (ITT). AE discontinuation = stopped study drug for any adverse event. Hover a status for its definition.

Verbatim quotes from the source (4)
  • 0.6 mg · hba1c · publication (abstract)
    At week 32, mean HbA1c reductions were 1·91% (SE 0·05; -20·86 mmol/mol [0·53]) with ecnoglutide 0·6 mg
  • 0.6 mg · ae_dc · publication
    six (3%) of 206 patients in the ecnoglutide 0·6 mg group, eight (4%) of 208 patients in the ecnoglutide 1·2 mg group, and six (3%) of 207 patients in the dulaglutide group discontinued treatment due to adverse events
  • 1.2 mg · hba1c · publication
    1·89% (0·05; -20·69 mmol/mol [0·54]) with ecnoglutide 1·2 mg, and 1·65% (0·05; -18·02 mmol/mol [0·53]) with dulaglutide.
  • 1.2 mg · ae_dc · publication
    six (3%) of 206 patients in the ecnoglutide 0·6 mg group, eight (4%) of 208 patients in the ecnoglutide 1·2 mg group, and six (3%) of 207 patients in the dulaglutide group discontinued treatment due to adverse events

Primary sources

How to cite this page

Medical Adviser's Group. Incretin Atlas: EECOH-2. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/trials/eecoh-2/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.

Cite the primary publication for any single result; every value above links to it.